Announcements and Notices - [Share Scheme]

Viva Biotech Holdings operates as a drug discovery platform. The Company provides target protein expression, structure researching, hit screening, drug candidate determination, and other services. Viva Biotech Holdings serves customers worldwide.

Grant Of Share Options

Financial Statements/ESG Information - [Interim/Half-Year Report]

Interim Report 2025

Announcements and Notices - [Interim Results]

Interim Results Announcement For The Six Months Ended June 30, 2025

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [Results of AGM]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Viva Biotech Holdings (1873 HK)

Grant Of Share Options

Interim Report 2025

Interim Results Announcement For The Six Months Ended June 30, 2025

Date Of Board Meeting

Poll Results Of The Annual General Meeting Held On June 12, 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)